APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,450,740 | -55.7% | 879,357 | +6.1% | 0.01% | -54.5% |
| Q2 2023 | $75,478,355 | +16.3% | 828,522 | -15.8% | 0.02% | +10.0% |
| Q1 2023 | $64,872,254 | +27.6% | 983,509 | +0.1% | 0.02% | +25.0% |
| Q4 2022 | $50,827,155 | -21.6% | 982,927 | +3.6% | 0.02% | -30.4% |
| Q3 2022 | $64,801,000 | +111.2% | 948,759 | +39.9% | 0.02% | +109.1% |
| Q2 2022 | $30,678,000 | -7.9% | 678,401 | +3.5% | 0.01% | +10.0% |
| Q1 2022 | $33,297,000 | +19.0% | 655,308 | +10.7% | 0.01% | +25.0% |
| Q4 2021 | $27,986,000 | +63.7% | 591,914 | +14.1% | 0.01% | +33.3% |
| Q3 2021 | $17,100,000 | -35.4% | 518,811 | +23.9% | 0.01% | -33.3% |
| Q2 2021 | $26,460,000 | +52.6% | 418,666 | +3.6% | 0.01% | +50.0% |
| Q1 2021 | $17,342,000 | -19.3% | 404,127 | +7.6% | 0.01% | -33.3% |
| Q4 2020 | $21,479,000 | +92.7% | 375,499 | +1.6% | 0.01% | +80.0% |
| Q3 2020 | $11,146,000 | -5.8% | 369,428 | +2.0% | 0.01% | -16.7% |
| Q2 2020 | $11,833,000 | +33.4% | 362,289 | +9.4% | 0.01% | +20.0% |
| Q1 2020 | $8,870,000 | +7.5% | 331,083 | +22.9% | 0.01% | +25.0% |
| Q4 2019 | $8,250,000 | +31.2% | 269,413 | +3.2% | 0.00% | 0.0% |
| Q3 2019 | $6,290,000 | +1.1% | 261,084 | +6.4% | 0.00% | 0.0% |
| Q2 2019 | $6,221,000 | +50.9% | 245,472 | +16.1% | 0.00% | +33.3% |
| Q1 2019 | $4,123,000 | +62.4% | 211,408 | +9.9% | 0.00% | +50.0% |
| Q4 2018 | $2,539,000 | -25.8% | 192,439 | -0.1% | 0.00% | 0.0% |
| Q3 2018 | $3,424,000 | -9.6% | 192,559 | +11.8% | 0.00% | -33.3% |
| Q2 2018 | $3,788,000 | +301.3% | 172,179 | +303.3% | 0.00% | +200.0% |
| Q1 2018 | $944,000 | +9.4% | 42,691 | +7.4% | 0.00% | 0.0% |
| Q4 2017 | $863,000 | – | 39,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |